CVS: 2019 To Be Transition Year Amid Drug Pricing Pressures

CVS Health chief executive Larry Merlo expects 2019 " headwinds " as the drugstore chain integrates Aetna amid drug pricing pressures and an underperforming Omnicare long-term care business.

Source: Forbes.com Healthcare News - February 20, 2019 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Tags: NYSE:CVS NYSE:AET Source Type: news